General - Press Releases

Date	Title	Company
11-Jun-2021	ADC Therapeutics Shareholders Approve All Resolutions at the Annual General Meeting	Businesswire
11-Jun-2021	Medical Refrigeration Systems Market Report 2021: Blood Bank, Laboratory, Vaccine, Pharmaceutical - Global Industry Analysis, Trends, Market Size, and Forecasts 2020-2026 - ResearchAndMarkets.com	Businesswire
11-Jun-2021	Global Plastic Resins Market Trends Analysis Report 2021 - World Market Forecast to Grow at a CAGR of 4.2% from 2021-2028 - ResearchAndMarkets.com	Businesswire
11-Jun-2021	Eight AstraZeneca UK employees recognised in The Queen’s Birthday Honours for their outstanding achievements in life sciences during the pandemic	AstraZeneca
11-Jun-2021	First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)	Businesswire
11-Jun-2021	Vertex and CRISPR Therapeutics Present New Data in 22 Patients With Greater Than 3 Months Follow-Up Post-Treatment With Investigational CRISPR/Cas9 Gene-Editing Therapy, CTX001™ at European Hematology Association Annual Meeting	Businesswire
11-Jun-2021	Caelum and Alexion Present Additional Phase 2 Data Reinforcing Safety and Tolerability of CAEL-101 in AL Amyloidosis at the European Hematology Association Congress 2021	Businesswire
11-Jun-2021	Bristol Myers Squibb and Acceleron Present First Results from Phase 2 BEYOND Study of Reblozyl® (luspatercept-aamt) in Adults with Non-Transfusion Dependent (NTD) Beta Thalassemia	Businesswire
11-Jun-2021	Heartseed Raises $37 Million in Series C Funding to Accelerate Development of iPSC-derived Stem Cell Therapy for Heart Failure	Businesswire
11-Jun-2021	BeiGene Presents ALPINE Results at EHA2021 Demonstrating Both Efficacy and Safety Advantages of BRUKINSA® (Zanubrutinib) in Head-to-Head Comparison to Ibrutinib in Chronic Lymphocytic Leukemia	Businesswire
11-Jun-2021	BeiGene Presents Long-Term Efficacy and Safety Results from Three Pivotal Trials of BRUKINSA® (Zanubrutinib) and Tislelizumab at EHA2021	Businesswire
11-Jun-2021	Celyad Oncology Presents Preliminary Data from Phase 1 IMMUNICY-1 Trial of shRNA-based Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the European Hematology Association Virtual Congress	Businesswire
11-Jun-2021	Genentech Announces Data at EHA2021 Reinforcing Efficacy of Venclexta Combinations in Chronic Lymphocytic Leukemia and Acute Myeloid Leukemia	Businesswire
11-Jun-2021	ISPRM 2021: New Ipsen Analysis Highlights Potential Treatment Gap in Adults Living With Spasticity	Businesswire
11-Jun-2021	New Genentech Data for Evrysdi (risdiplam) Show Improved Motor Function in Pre-Symptomatic Babies After One Year and Confirm Safety Profile in Previously Treated People With Spinal Muscular Atrophy (SMA)	Businesswire
10-Jun-2021	AbCellera Announces Secondary Private Sale of 11.9 Million Common Shares	Businesswire
10-Jun-2021	Supercharging Public-Private Efforts in the Race to Net-Zero and Climate Resilience	Businesswire
10-Jun-2021	Tyme Technologies, Inc. Completes Strategic Review, Announces OASIS Breast Trial With Georgetown University, and Reports Fiscal Year 2021 Financial Results	Businesswire
10-Jun-2021	EchoNous Fast-Tracks VA DoD Purchasing with Medical Equipment ECAT Contract	Businesswire
10-Jun-2021	Onxeo: Report on the Combined General Meeting of June 10, 2021	Businesswire